| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |